In prostate cancer cells with p53 mutations, a similar mechanism may operate, as these cells exhibit high expression and pro-migratory signalling of EGFR and altered expression of the APPL1 protein, consistent with increased endosomal recycling [8,237,238]. Here, TP53 is linked to prostate carcinoma.